Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on ARIAD PHARMACEUTICALS, INC
4d ago ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Data Presentations and Webcast of ..
6d ago ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at UBS Global Healthcare Conferen..
05/07 ARIAD PHARMACEUTICALS, INC.: ARIAD Reports First Quarter 2013 Financial Results..
05/06 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Bank of America Merrill Lynch ..
04/26DJAs Biotechnology Stocks Soar, Bubble Talk Percolates
04/23 ARIAD PHARMACEUTICALS, INC.: ARIAD to Host Conference Call and Webcast Discussi..
04/10 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents New Preclinical Data Showing AP2611..
04/09 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents New Preclinical Data Showing Ponati..
04/08 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents New Preclinical Data Showing Ponati..
04/04 ARIAD PHARMACEUTICALS, INC.: ARIAD Provides Update on Important Progress Being ..
04/03 ARIAD PHARMACEUTICALS, INC.: CORRECTING and REPLACING ARIAD to Host Investor Co..
04/02 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Support of Patients with Resistant..
03/22 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces That Iclusig? (Ponatinib) Receives..
03/20 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Presentations of Preclinical Data ..
03/06 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Barclays Global Healthcare Con..
02/28 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the Cowen and Company 33rd Ann..
02/25 ARIAD PHARMACEUTICALS, INC.: ARIAD Reports 2012 Financial Results and Outlines ..
02/21 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Appointment of European General Ma..
02/20ARIAD PHARMACEUTICALS, INC.: quaterly earnings release
02/19 ARIAD PHARMACEUTICALS, INC.: ARIAD To Present at The RBC Capital Markets Health..
02/08 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the Leerink Swann Global Healt..
02/05 ARIAD PHARMACEUTICALS, INC.: ARIAD to Webcast Conference Call on Fourth Quarter..
01/29 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Completion of Public Offering
01/24DJARIAD PHARMACEUTICALS, INC.: Ariad's 15.3 Million Share Offering Prices at 1.3%..
01/24 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Pricing of Public Offering of Comm..
01/24DJU.S. HOT STOCK FUTURES: Hot stocks to watch
01/23 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Proposed Public Offering of Common..
01/07 ARIAD PHARMACEUTICALS, INC.: ARIAD and the U.K. National Cancer Research Instit..
01/02 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the 31st Annual J.P. Morgan He..
2012DJFDA Approves Iclusig to Treat Two Rare Types of Leukemia
2012 ARIAD PHARMACEUTICALS, INC.: CORRECTING and REPLACING and ADDING MULTIMEDIA ARI..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces 12-Month Data from Pivotal PACE Tr..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Long-Term Molecular Response Data ..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces 12-Month Data from Pivotal PACE Tr..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Ponatinib Presentations at Annual ..
2012DJMerck Withdraws Marketing Authorization Application for Bone Cancer Treatment
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Publication of Ponatinib Phase 1 C..
2012 ARIAD PHARMACEUTICALS, INC.: Foundation Medicine and ARIAD Announce Collaborati..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the Lazard Capital Markets Hea..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Reports Third Quarter 2012 Financial Results..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Webcast Conference Call on Third Quarter ..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces U.S. Food and Drug Administration ..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Host Analyst & Investor Day in New York C..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents Initial Clinical Proof-of-Concept o..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Completes Rolling Submission of New Drug App..
2012 ARIAD PHARMACEUTICALS, INC.: MolecularMD and ARIAD Announce Voluntary Withdrawa..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Initial Data on AP26113, Investiga..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the UBS Global Life Sciences C..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Upcoming Investor Conferences
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Submission of Marketing Authorizat..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the Stifel Nicolaus Healthcare..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Begins Phase 1/2 Trial of Ponatinib in Japan
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Reports Second Quarter 2012 Financial Result..
2012 ARIAD PHARMACEUTICALS, INC.: Ariad Announces Submission of New Drug Application..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Initiation of Randomized Phase 3 T..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Webcast Conference Call on Second Quarter..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the JMP Securities 2012 Health..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Webcast of Its Annual Shareholders..
2012DJFDA Rejects Merck's Treatment for Bone Cancer
2012DJFDA Rejects Merck's Treatment For Bone Cancer
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Updated Data from Pivotal PACE Tri..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Upcoming Investor Conferences
2012 ARIAD PHARMACEUTICALS, INC.: Ariad Announces Updated Findings from Pivotal Pace..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Bank of America Merrill Lynch ..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Reports First Quarter 2012 Financial Results..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD To Present at the Deutsche Bank 37th Annual ..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Webcast Conference Call on First Quarter ..
2012 New Amgen CEO must win investors with payouts, deals
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents New Preclinical Data on Ponatinib a..
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Presentations of Preclinical Data ..
2012 ARIAD PHARMACEUTICALS, INC.: Merck and ARIAD Pharmaceuticals Provide Update on ..
2012DJFDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients
2012DJFDA Panel To Review Merck, Glaxo Drugs For Soft-Tissue Sarcoma
2012DJFDA Panel To Review Merck, Glaxo Drugs For Soft-Tissue Sarcoma
2012 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Barclays Capital Global Health..
1  2  3Next
Advertisement
Chart
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Income Statement Evolution
Ariad Pharmaceuticals, Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.